Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,500 shares at $355.12 ($532K) on 2021-04-29, disclosed to the SEC on 2021-05-03.
Open-market sale of $532k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $350.25 | 100 | $35K | 6.6% |
| 2 | $352.67 | 200 | $71K | 13.2% |
| 3 | $353.94 | 300 | $106K | 19.9% |
| 4 | $355.12 | 400 | $142K | 26.7% |
| 5 | $356.25 | 300 | $107K | 20.1% |
| 6 | $358.62 | 200 |
| $72K |
| 13.5% |
| Total | $354.93 avg | 1,500 | $532K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |